Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Bioscience Animal Health PCL's average Total Assets Growth Rate was -17.20% per year.
During the past 3 years, the average Total Assets Growth Rate was -1.70% per year.
During the past 5 years, the average Total Assets Growth Rate was 4.60% per year.
During the past 9 years, Bioscience Animal Health PCL's highest 3-Year average Total Assets Growth Rate was 40.50%. The lowest was -1.70%. And the median was 8.00%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Bioscience Animal Health PCL's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Bioscience Animal Health PCL Total Assets Related Terms
Bioscience Animal Health PCL Total Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioscience Animal Health PCL Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioscience Animal Health PCL (BKK:BIS) has a Total Assets of ฿1,204 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Bioscience Animal Health PCL and its competitors.
Is Bioscience Animal Health PCL's Total Assets too high?
Bioscience Animal Health PCL's current Total Assets is ฿1,204 Mil. Overall, Bioscience Animal Health PCL has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioscience Animal Health PCL's Total Assets compare to KHC and GIS?
Bioscience Animal Health PCL's Total Assets of ฿1,204 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Consumer Packaged Goods company?
A good Total Assets depends on the Consumer Packaged Goods industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Bioscience Animal Health PCL and its competitors. Bioscience Animal Health PCL's current Total Assets is ฿1,204 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioscience Animal Health PCL stock overvalued right now?
Based on GuruFocus' analysis, Bioscience Animal Health PCL (BKK:BIS) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.86, compared to a current price of ฿2.26 — trading 21% below its estimated fair value. The current Total Assets is ฿1,204 Mil. Bioscience Animal Health PCL's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Bioscience Animal Health PCL (BKK:BIS), the current Total Assets is ฿1,204 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioscience Animal Health PCL (BKK:BIS) Overvalued in 2026?
Based on GuruFocus' analysis, Bioscience Animal Health PCL stock appears to be undervalued.
The current stock price of ฿2.26 is trading 21% below its estimated GF Value™ of ฿2.86.
GuruFocus considers Bioscience Animal Health PCL to be Modestly Undervalued.
Key valuation signals for BKK:BIS:
Total Assets: ฿1,204 Mil
GF Value™: ฿2.86 vs. price of ฿2.26 (21% below fair value)
No single metric tells the full story. See the BKK:BIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
83GF Score
Get the complete analysis for BKK:BIS
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIS has been successfully added to your 
